Headlands Technologies LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,463 shares of the company's stock, valued at approximately $359,000.
A number of other institutional investors have also made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health during the 4th quarter worth about $26,000. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC lifted its holdings in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quarry LP boosted its stake in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after purchasing an additional 2,628 shares during the period. Finally, Blue Trust Inc. increased its position in Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after buying an additional 681 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.64% of the company's stock.
Option Care Health Price Performance
Shares of OPCH traded up $0.77 during mid-day trading on Wednesday, reaching $33.56. The company had a trading volume of 4,027,447 shares, compared to its average volume of 1,753,618. The company's 50 day simple moving average is $33.17 and its 200 day simple moving average is $28.58. The company has a market capitalization of $5.51 billion, a price-to-earnings ratio of 28.20, a P/E/G ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.
Analysts Set New Price Targets
Several equities analysts recently commented on OPCH shares. Barrington Research upped their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and a consensus target price of $33.00.
View Our Latest Stock Analysis on OPCH
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
